Mingzhi Zhang Selected Research

Open-Angle Glaucoma (Glaucoma, Open Angle)

4/2024	Profile of Lipoprotein Subclasses in Chinese Primary Open-Angle Glaucoma Patients.
4/2024	Oxidized low-density lipoprotein changes the inflammatory status and metabolomics profiles in human and mouse macrophages and microglia.
3/2024	Untargeted and Oxylipin-Targeted Metabolomics Study on the Plasma Samples of Primary Open-Angle Glaucoma Patients.
11/2023	Primary open-angle glaucoma risk prediction with ABCA1 and LOC102723944 variants and their genotype-phenotype correlations in southern Chinese population.
7/2015	A common variant near TGFBR3 is associated with primary open angle glaucoma.
2/2014	Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.
1/2012	Evaluation of NTF4 as a causative gene for primary open-angle glaucoma.
1/2012	SNP rs1533428 at 2p16.3 as a marker for late-onset primary open-angle glaucoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mingzhi Zhang Research Topics

Disease

91	Neoplasms (Cancer) 02/2024 - 05/2009
46	Lymphoma (Lymphomas) 03/2024 - 09/2011
25	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 04/2013
22	T-Cell Lymphoma (Lymphoma, T Cell) 03/2024 - 05/2004
17	Hypertension (High Blood Pressure) 08/2022 - 04/2011
13	Inflammation (Inflammations) 04/2024 - 03/2012
10	Obesity 01/2022 - 04/2014
9	Neoplasm Metastasis (Metastasis) 11/2023 - 05/2009
8	Open-Angle Glaucoma (Glaucoma, Open Angle) 04/2024 - 01/2012
8	Glaucoma 04/2024 - 02/2010
8	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 11/2018
8	Myopia 01/2023 - 08/2011
8	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2016
8	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 11/2013
8	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 11/2015
7	Hodgkin Disease (Hodgkin's Disease) 03/2024 - 01/2017
7	Glioma (Gliomas) 02/2024 - 08/2015
7	Carcinogenesis 01/2024 - 02/2015
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2023 - 12/2014
7	Cataract (Cataracts) 08/2023 - 12/2007
7	Refractive Errors (Refractive Error) 01/2023 - 12/2007
6	Macular Degeneration (Age-Related Maculopathy) 12/2022 - 01/2013
6	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 11/2015
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 09/2013
5	Stroke (Strokes) 01/2023 - 07/2016
5	Extranodal NK-T-Cell Lymphoma 01/2022 - 11/2014
5	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021 - 03/2016
5	Carcinoma (Carcinomatosis) 01/2018 - 12/2014
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2024 - 03/2016
4	Astigmatism 10/2022 - 08/2011
4	Ischemic Stroke 06/2022 - 06/2014
4	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2015
4	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2013
4	Ganglion Cysts (Ganglion) 05/2019 - 01/2016
3	Disease Progression 01/2024 - 01/2019
3	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 01/2016
3	Leukemia 06/2022 - 08/2015
3	Infections 01/2022 - 12/2014

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2009
18	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 01/2012
18	Rituximab (Mabthera)FDA Link 02/2024 - 04/2013
16	Biomarkers (Surrogate Marker)IBA 10/2023 - 06/2013
16	Retinaldehyde (Retinal)IBA 05/2023 - 03/2008
14	Chimeric Antigen ReceptorsIBA 01/2024 - 09/2015
14	LipidsIBA 08/2023 - 04/2011
14	Gemcitabine FDA Link 01/2022 - 11/2014
12	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 03/2012
11	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 02/2007
9	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 04/2011
9	pegaspargase (Oncaspar)FDA Link 01/2022 - 11/2014
8	Prednisone (Sone)FDA LinkGeneric 02/2024 - 01/2017
8	Transcription Factors (Transcription Factor)IBA 11/2023 - 01/2012
8	Etoposide (VP 16)FDA LinkGeneric 04/2023 - 01/2018
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2014
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 01/2017
7	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2011
7	Messenger RNA (mRNA)IBA 10/2019 - 02/2007
6	Vincristine (Oncovin)FDA LinkGeneric 02/2024 - 01/2017
6	Natriuretic PeptidesIBA 01/2023 - 01/2020
6	Monoclonal AntibodiesIBA 12/2022 - 08/2015
5	Insulin (Novolin)FDA Link 05/2024 - 04/2011
5	RNA (Ribonucleic Acid)IBA 04/2024 - 12/2015
5	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2024 - 01/2018
5	Circular RNAIBA 09/2022 - 11/2019
5	Thalidomide (Thalomid)FDA Link 01/2022 - 01/2017
5	AlbuminsIBA 01/2022 - 01/2018
5	ibrutinibIBA 01/2022 - 03/2016
5	Long Noncoding RNAIBA 01/2021 - 09/2017
5	LigandsIBA 08/2020 - 04/2012
5	C-Reactive ProteinIBA 07/2019 - 06/2013
5	Pyruvic Acid (Pyruvate)IBA 02/2017 - 10/2015
4	CytokinesIBA 03/2024 - 12/2014
4	EnzymesIBA 01/2024 - 08/2016
4	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 10/2023 - 01/2020
4	Methotrexate (Mexate)FDA LinkGeneric 08/2023 - 11/2013
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2017
4	AntibodiesIBA 01/2023 - 08/2020
4	Atrial Natriuretic Factor (ANF)IBA 08/2022 - 01/2020
4	FurinIBA 04/2021 - 11/2019
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2021 - 11/2015
4	AntigensIBA 08/2020 - 09/2015
4	Oxidoreductases (Dehydrogenase)IBA 02/2017 - 10/2015
4	Small Interfering RNA (siRNA)IBA 02/2015 - 01/2012
3	oxidized low density lipoproteinIBA 04/2024 - 04/2014
3	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 03/2016
3	Bendamustine Hydrochloride FDA Link 02/2024 - 10/2022
3	Biosimilar PharmaceuticalsIBA 01/2024 - 01/2020
3	Adenosine Triphosphate (ATP)IBA 11/2023 - 12/2015
3	fotemustine (Muphoran)IBA 01/2023 - 11/2018
3	N-propionylprocainamideIBA 01/2022 - 01/2020
3	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2020
3	Asparaginase (Elspar)FDA Link 01/2022 - 01/2017

Therapy/Procedure

44	Therapeutics 03/2024 - 12/2010
30	Drug Therapy (Chemotherapy) 03/2024 - 05/2013
16	Immunotherapy 03/2024 - 09/2015
10	Radiotherapy 01/2024 - 11/2013
5	Eyeglasses (Spectacles) 01/2023 - 12/2008
3	Photorefractive Keratectomy 10/2022 - 03/2019
3	Phacoemulsification 10/2022 - 09/2013
3	Laser In Situ Keratomileusis (LASIK) 10/2022 - 11/2013